Impact of direct oral anticoagulant off‐label doses on clinical outcomes of atrial fibrillation patients: A systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of direct oral anticoagulant off‐label doses on clinical outcomes of atrial fibrillation patients: A systematic review

Published:2020-02-05 Issue:3 Volume:86 Page:533-547
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Santos Joana¹,António Natália²³⁴,Rocha Marília⁵,Fortuna Ana¹⁶⁷^ORCID

Affiliation:

1. Laboratory of Pharmacology and Pharmaceutical Care, Faculty of Pharmacy University of Coimbra Coimbra Portugal

2. Laboratory of Pharmacology, Faculty of Medicine University of Coimbra Portugal

3. Cardiology Department Coimbra Hospital and Universitary Centre Portugal

4. Coimbra Institute for Clinical and Biomedical Research (iCBR) Coimbra Portugal

5. Pharmaceutical Service Coimbra Hospital and Universitary Centre Portugal

6. Center for Neuroscience and Cell Biology University of Coimbra Coimbra Portugal

7. CIBIT/ICNAS ‐ Coimbra Institute for Biomedical Imaging and Translational Research University of Coimbra Coimbra Portugal

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14127

Reference86 articles.

1. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?

2. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups

3. Management of Patients on Non–Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association

4. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

5. Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events;International Journal of Cardiology;2024-12

2. Comparative Effectiveness and Safety of Off-Label Underdosed Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis;Drug Safety;2024-08-30

3. Plasma apixaban concentrations and thrombin generation assay parameters in response to dose reduction for atrial fibrillation;British Journal of Clinical Pharmacology;2024-08-15

4. Frequency of and factors associated with underdosing of direct oral anticoagulants in patients with ischaemic stroke and atrial fibrillation;Neurology Perspectives;2024-07

5. How I treat the co-occurrence of venous and arterial thromboembolism: anticoagulation, antiplatelet therapy, or both?;Blood;2024-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3